Mandaviya to review Covid-19 situation amid spurt in cases in US, China

Amid a fresh spurt in Covid-19 cases in Japan, South Korea, Brazil, China and the US, Union Health Minister Mansukh Mandaviya will review the pandemic situation on Wednesday, official sources said

Mansukh Mandaviya
Press Trust of India New Delhi
2 min read Last Updated : Dec 20 2022 | 9:44 PM IST

Amid a fresh spurt in COVID-19 cases in Japan, South Korea, Brazil, China and the US, Union Health Minister Mansukh Mandaviya will review the pandemic situation on Wednesday, official sources said.

The minister will review the COVID-19 situation at 11 am on Wednesday considering the international scenario, they said.

Earlier on Tuesday, the Health Ministry urged all states and Union territories to ramp up the whole genome sequencing of positive samples to keep track of newer variants.

In a letter to states and UTs, Union Health Secretary Rajesh Bhushan said such an exercise will enable timely detection of newer variants, if any, circulating in the country and will facilitate undertaking of requisite public health measures.

He highlighted that India with its focus on the five-fold strategy of test-track-treat-vaccination and adherence to Covid-appropriate behaviour has been able to restrict the transmission of the coronavirus and is having around 1,200 cases on a weekly basis.

Public health challenge of COVID-19 still persists around the world with around 35 lakh cases being reported weekly, Bhushan said.

"In view of the sudden spurt of cases being witnessed in Japan, United States of America, Republic of Korea, Brazil and China, it is essential to gear up the whole genome sequencing of positive case samples to track the variants through Indian SARS-CoV-2 Genomics Consortium (INSACOG) network," he said.

"In this context, all states are requested to ensure that as far as possible samples of all positive cases, on a daily basis, are sent to the designated INSACOG Genome Laboratories that are mapped to states and UTs," he added.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :CoronavirusMansukh Lal MandaviyaJapan

First Published: Dec 20 2022 | 9:44 PM IST

Next Story